SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Bentley Pharmaceuticals (BNT) -- Ignore unavailable to you. Want to Upgrade?


To: KIRK JONES who wrote (14)5/15/1998 1:41:00 PM
From: Roger Greene  Read Replies (1) | Respond to of 17
 
Interesting comments in 10Q:
"In appropriate situations, that will be strategically determined, the Registrant may seek financial assistance from other sources, including contribution by others to joint ventures and other collaborative or licensing arrangements for the development, testing, manufacturing and marketing of products under development and the sale of certain of the assets of, or its subsidiary. As discussed above, the Registrant has entered into a letter of intent to acquire pharmaceutical products and a manufacturing facility in the United States. The Registrant must finance the acquisition of these assets and is exploring various options intended to secure such financing. The Registrant has amended its letter of intent to take into consideration the possible transfer of control of its Spanish subsidiary to Schwarz Pharma USA Holdings, Inc."
See sec.yahoo.com